Yorkshire Cancer Research has today (Wednesday, March 15) announced a £4.9m programme of research to tackle cancer inequalities in Hull.
The charity will work in partnership with the University of Hull, the Hull York Medical School and Hull and East Yorkshire Hospitals NHS Trust to deliver a series of five-year research projects that will improve the experience of cancer patients and ensure more people in the city survive the disease.
The initiative will focus on ensuring that patients are diagnosed at the earliest possible stage and that they have equal access to the very best treatments and supportive care.
The investment will fund the appointment of 11 of the country’s most promising researchers, who will help to establish the city as a centre of excellence for cancer research, and the programme is expected to attract further national funding to the area.
Dr Kathryn Scott, Interim Chief Executive at Yorkshire Cancer Research, said: “This investment is another huge step in achieving our goal to save 2,000 more lives in Yorkshire every year by 2025. We know we can have a significant impact in Hull by making sure people know how to spot the signs and symptoms of cancer and when to visit the doctor, but also that they understand the importance of attending screening appointments.
“We also need to work with GPs to ensure they are able to refer possible cancer patients to hospital as quickly as possible, and that healthcare professionals are able to deliver the best possible care to patients and their families once they have been referred.”
Hull is the most deprived local authority in Yorkshire and the third most deprived in the country1. Areas with high levels of deprivation often have poor cancer outcomes. The reasons behind this include higher levels of unhealthy behaviours, such as smoking and drinking alcohol, poor knowledge and awareness of symptoms, and barriers in access to healthcare.
There are an estimated 8,720 people in Hull currently living with or beyond cancer2. Lung cancer incidence and mortality rates in the area are significantly higher than the national average3. Survival rates in Hull also lag behind the England and Yorkshire averages4.
In 2016, just over a quarter of cancer patients in Hull were diagnosed with Stage 4 disease, the most advanced type5. When cancer is diagnosed at a late stage there are often fewer treatment options and the chances of survival can be lower.
Professor Glenn Burgess, Acting Vice-Chancellor at the University of Hull, said: “This award is significant news for Yorkshire. It is testament to the world-class research and innovation delivered by the University and Hull York Medical School that we have won this funding from Yorkshire Cancer Research to carry out this important work.
“This research will not only contribute to transforming the way our hospitals and GPs work but will also have an impact for those suffering from cancer, their families and carers.”
Professor Una Macleod, Dean of Hull York Medical School, said: “We want to radically change the life chances of people in our region living with cancer and this funding from Yorkshire Cancer Research will help us make this aim a reality.
“We welcome the funding from Yorkshire Cancer Research for this important area of research to reduce inequalities in cancer outcomes and improve survival rates in Yorkshire.
“Cancer incidence, mortality and survival rates are often worse for those living in Yorkshire than across England as a whole, and they are especially bad in Hull. The picture worsens for the elderly and for those from socially-deprived communities. These research projects will help us understand why these differences exist, and how to reduce inequalities, speed up referrals, and improve access to care and treatment.”
Chris Long, Chief Executive at Hull and East Yorkshire Hospitals NHS Trust, said: “The big challenge we’ve got in this area is that just over a quarter of patients report to their doctor when their tumours are at grade 4, which is the most advanced level of cancer. This reduces our options for treatment and often ends up with the patients having a shortened life as a consequence.
“Research grants like these are really important and I’m so grateful to Yorkshire Cancer Research for the work they are funding in Hull. By working in partnership with the University of Hull and the Hull York Medical School we can attract good quality researchers into the area and they can work alongside practitioners who are actually delivering care. This means we can identify new ways to diagnose people at the earliest possible stage and improve treatment to ensure local people get better outcomes for their illness.”
The project will take place over a period of five years in the new Allam Medical Building, at the heart of the University’s £28 million health campus which will be the home for world-leading research and innovative teaching.
These grants will build on five other significant research projects* that are already ongoing at the University, also funded by Yorkshire Cancer Research. The University is making a significant contribution through this work to help Yorkshire Cancer Research have a real impact on patients’ lives and healthcare in Yorkshire.
* The five previous awards from Yorkshire Cancer Research include:
- A £92,000 award to Professor Michael Lind, who is investigating whether a mutation found in some lung cancers could be detected using a blood test rather than a biopsy.
- A £300,000 award to Professor Miriam Johnson, who is testing an enhanced GP system developed to improve access to palliative care.
- A £190,000 award to Dr Peter Knapp, who is investigating why patients with suspected cancer do not turn up for urgent appointments.
- A £135,000 award to Professor Una Macleod, who is investigating why older women are less likely to attend cervical cancer screening appointments, and aims to develop training and awareness resources to encourage them to get tested.
- A £750,000 award to Professor Una Macleod, who began a five-year investigation into issues relating to the diagnosis and experience of people with cancer in Hull in 2013.
1. PHE Health Profiles https://fingertips.phe.org.uk/
2. Local Cancer Intelligence, Prevalence, http://lci.cancertoolkit.co.uk/Prevalence, Accessed [March 2017].
3. CancerData, Incidence and Mortality, https://www.cancerdata.nhs.uk/, Accessed [March 2017].
4. Office for National Statistics, Index of cancer survival for Clinical Commissioning Groups in England: adults diagnosed 1999 to 2014 and followed up to 2015, https://www.ons.gov.uk/, Accessed [March 2017].
5. Public Health England, National Cancer Registration and Analysis Service http://www.ncin.org.uk/search/stage+by+ccg
About Yorkshire Cancer Research
- Harrogate-based Yorkshire Cancer Research is the UK’s largest regional medical research charity (registered charity no. 516898)
- We are committed to reducing the devastating impact of cancer on the lives of people living in Yorkshire.
- Our mission is to work in partnership, fund research and support initiatives that will help people in Yorkshire avoid, survive and cope with cancer.
- Current statistics show that 565 people are diagnosed with cancer in Yorkshire every week. Incidence and mortality rates are higher than the England average due to social deprivation, post-industrialisation and lifestyle choices but also availability of healthcare services and difficulties accessing early diagnostics, clinical trials and the latest treatments.
- We aim to:
- Be the leading authority on cancer in Yorkshire, understanding the problems and priorities in the region and sharing knowledge with partners.
- Raise awareness of cancer and how to prevent it by working in local communities, schools and colleges, sports clubs and with other health-related organisations.
- Promote screening programmes and fund research that can improve the diagnosis of cancer so we can detect and treat it at the earliest opportunity.
- Invest in innovative research projects at every stage of a cancer patient’s journey.
- Campaign for fair and equal access to the very best healthcare services and a greater share of the money spent nationally on research.
- For further information, please visit www.yorkshirecancerresearch.org.uk or follow us on Facebook or Twitter.
- Nikki Brady, Senior PR Officer – Yorkshire Cancer Research
- Tel: 01423 877 228
About the University of Hull
As well as having a strong and dynamic culture in health research, the University plays a pivotal role in the region’s health in terms of training the workforce. We train many of the region’s doctors, nurses and midwives and pioneer research to tackle the biggest health challenges facing society.
A new £28-million health campus is a signal of the University’s commitment and will realise the University’s bold ambitions to be at the forefront of medical, nursing, midwifery and allied health training, as well as offering a world-leading research centre. The health campus, due for completion in late 2017, will offer training in ‘real-life’ settings including an operating theatre and mock hospital ward which will mean our students are better prepared than ever to join the region’s workforce.
About the Hull York Medical School
Hull York Medical School (HYMS) is a partnership between the two well-established Universities of Hull and York. Since opening in 2003, HYMS has become known as one of the UK’s most welcoming and inclusive medical schools with a reputation for innovative, inspiring, exciting and rigorous medical education. We are committed to ensuring that our students graduate from Hull York Medical School as excellent thinkers, evidence based practitioners and patient-centred communicators who are thoroughly prepared for clinical practice.
HYMS’s researchers conduct world-class research, much of this is interdisciplinary, spanning traditional subject boundaries and reaching out into other departments within the Universities of Hull and York. Our research spans those issues which are of critical importance to the country and the NHS including primary care, mental health, palliative care, public health and other applied clinical areas and in some key translational biomedical areas in thrombosis, haemostasis and metabolism, and immunology and infection. Research undertaken has attracted significant grants and funding including from Marie Curie (£118,682K to improve the care of those with chronic lung conditions), the Wolfson Foundation (£500k to help create a world-leading centre for research into palliative care), Cancer Research UK (£343K to understand emergency presentation of lung and colorectal cancer) and from the British Heart Foundation (£900k to pursue cardiovascular and metabolic research). We strive for excellence in our research with 85% considered world-leading or internationally excellent (REF 2014).
Facebook: Hull York Medical School
- Last updated: 15/03/2017
- View more in: News